Omi C A, De Almeida G V, Cohen R, Mandia C, Kwitko S
Department of Ophthalmology of Escola Paulista de Medicina, São Paulo, Brazil.
Ophthalmology. 1991 Feb;98(2):211-4. doi: 10.1016/s0161-6420(91)32315-7.
Fifty-five eyes of 51 patients with different forms of refractory glaucoma (15 aphakic, 12 neovascular, 9 postpenetrating keratoplasty, 8 congenital, 5 secondary to uveitis, 4 associated with aniridia, 1 pseudophakic, and 1 traumatic) underwent antiglaucomatous surgery using a modified 90 degrees Schocket implant. In 25 eyes (45.4%), this was the first surgical procedure. Follow-up ranged from 3 to 27 months (mean, 10.3 +/- 5.4 months). The mean preoperative intraocular pressure (IOP) was 39.5 +/- 8.6 mmHg (range, 22 to 66 mmHg). The mean postoperative IOP was 17.8 +/- 7.6 mmHg (range, 4 to 50 mmHg). Intraocular pressure remained less than 21 mmHg in 50 eyes (90.9%) during the follow-up period. In 13 of these eyes (26.0%), IOP remained under control without any medication. Complications were observed in 13 eyes (23.6%) and were successfully treated in 11 of them. Complications included iris-tube block (5.4%), vitreous-tube block (3.6%), early postoperative flat anterior chamber (1.8%), choroidal effusion (3.6%), tube exteriorization from anterior chamber (3.6%), tube displacement from silicone band (1.8%), retinal detachment (1.8%), tube-cornea touch (1.8%), vitreous hemorrhage (1.8%), infectious endophthalmitis (1.8%), and phthisis bulbi (1.8%). Modified 90 degrees Schocket implants are an effective technique in the management of refractory glaucoma.
51例患有不同类型难治性青光眼的患者(15例无晶状体眼、12例新生血管性、9例穿透性角膜移植术后、8例先天性、5例葡萄膜炎继发、4例与无虹膜相关、1例人工晶状体眼和1例外伤性)的55只眼睛接受了使用改良90度Schocket植入物的抗青光眼手术。25只眼睛(45.4%)是首次手术。随访时间为3至27个月(平均10.3±5.4个月)。术前平均眼压(IOP)为39.5±8.6 mmHg(范围22至66 mmHg)。术后平均眼压为17.8±7.6 mmHg(范围4至50 mmHg)。随访期间50只眼睛(90.9%)的眼压保持低于21 mmHg。其中13只眼睛(26.0%)眼压无需任何药物即可得到控制。13只眼睛(23.6%)观察到并发症,其中11只成功治疗。并发症包括虹膜-引流管阻塞(5.4%)、玻璃体-引流管阻塞(3.6%)、术后早期无前房(1.8%)、脉络膜渗漏(3.6%)、引流管自前房脱出(3.6%)、引流管自硅胶带移位(1.8%)、视网膜脱离(1.8%)、引流管-角膜接触(1.8%)、玻璃体积血(1.8%)、感染性眼内炎(1.8%)和眼球痨(1.8%)。改良90度Schocket植入物是治疗难治性青光眼的一种有效技术。